Abbott
ABT
Performance
About Abbott
Abbott is a global healthcare company that designs and manufactures medical devices and diagnostic solutions across cardiovascular health, diabetes management, nutrition, diagnostics testing, and related areas. With operations based in Chicago, Illinois, Abbott develops technologies and therapies to improve patient outcomes and quality of life worldwide. The company emphasizes life-changing healthcare technologies and a broad portfolio spanning medical devices, diagnostics, and medicines. Abbott serves patients and health systems globally, with products and solutions addressing a wide range of medical needs.
Recent News
Abbott Increases Quarterly Dividend for 54th Consecutive Year
Culturally Tailored Meals Improve HF Outcomes in Navajo Residents
Roche Secures CE Mark for Elecsys NfL Blood Test to Track MS Neuroinflammation
Conduction System Pacing Defibrillator Lead Successful in Trial
Whoop Secures $575 M Series G, Hits $10 B Valuation Ahead of IPO
Whoop Secures $575M at $10.1B Valuation Ahead of IPO Plans
Medtronic Secures FDA Clearance for Mosaic Neo Mitral Valve Bioprosthesis
Stryker Closes Amplitude Vascular Acquisition
First Bedside Procedure of Its Kind Performed by Traveling Clinicians on Premature Infant
Science Shorts: Vitamin D, Postbiotics, HMB Protein, NMN in the Spotlight
Abbott's Wireless Heart Failure Sensor Cleared for NHS Use
Exact Sciences Stockholders Approve Acquisition by Abbott
Calcium Score Predictive of ASCVD Risk From Elevated Lp(a)
European Corporate Divestitures in Healthcare Technology and MedTech: 2026 Trends, Predictions and Analysis
Value, Focus, and the Future of MedTech: M&A and Divestitures Are Rewriting the Strategic Playbook.
Should Moderate FMR Should Be Treated With M-TEER? Experts Duke It Out
Australian Study Finds 90% Value Muscle Health, Yet Only 9% Seek Professional Help
What the Smart Money Just Bought in Healthcare and Life Sciences VC Over the Last Sixty Days
Critical Mass With Law.com's Amanda Bronstad: 13 Lawyers Line Up to Lead Talc MDL's Next Phase, Jury Awards $5K in Uber Sexual Assault Bellwether Trial
WHOOP’s $575 Million Raise Signals the Global Interest in Health Wearables
Apothecon Group Names Shyamakant Giri CEO to Drive Specialty Formulations Growth
Musk Taps Former U.S. Solicitor General To Represent X In 'Ad Boycott' Appeal
PFA Has Been a Game-Changer for Heart Patients—But There Are Still Risks
MiniMed Posts Double-Digit Sales Growth, Widening Net Loss
Boston Scientific Slashes 2026 Guidance
Musk Appeals Dismissal Of Ad Boycott Suit Against WFA, Others
Dexcom Unveils G8 CGM, a 50% Smaller Sensor Set for 2027 Launch
Pevifoscorvir Shows Strong HBV Activity, Durable Antigen Suppression
Medtronic Bets on Cardiovascular Realignment Amid Stock Pressure and Facility Closures
GlucoTrack Shares Jump 34% as FDA IDE Submission Looms for Implantable Glucose Monitor
Senseonics Rolls Out Eversense 365, First One‑Year CGM, Across Europe
Medikit Co Ltd Posts 5.4% Revenue Rise to ¥23.8 Bn, Profit of ¥3.0 Bn
HHS’ Healthy Food Agenda Puts Hospitals on Notice About Patients’ Meals
Leadless, Dual-Chamber Pacemakers for NB Patients
Labcorp Expands Epic Pact to Make Full Test Menu Available on Aura
Medtronic Wins CE Mark for OmniaSecure Defibrillation Lead
Evolution of the European HealthTech and MedTech Advisory Ecosystem: Rise of Founder Bankers and Specialist Boutiques
Whoop Secures $575 M Series G at $10.1 B Valuation, Accelerating Corporate Wellness Push
Maurten Nutrition Powers Sabastian Sawe’s Sub‑2‑Hour Marathon Record
Biopharma Money Raised: Jan. 1-April 23, 2026
Kevin Durant Whoop Valuation Up 81x Since His 2017 Investment
Bruno Vision Care Wins 2026 MedTech Breakthrough Award
Conavi Medical Secures FDA Clearance for Hybrid IVUS‑OCT Imaging System
Google Unveils Screenless Fitbit Air, New Google Health App
Questions Cloud Latest Danone Link to Mead Johnson
Abbott Elevates Jenil Sheth to Head of Marketing, Boosting Healthcare Brand Strategy
Insulet Launches Pivotal Trial of Fully Closed‑Loop Insulin System for Type 2 Diabetes
Abbott Gains FDA Clearance, CE Mark Approval for AI-Powered Imaging Platform
Multiple CGM Sensors May Be Used with Automated Insulin Delivery
VDyne Secures FDA Nod to Start Pivotal Trial for Tricuspid Valve